Vytala achieves a milestone with successful launch of Seracal and initiates IRB-approved study to expand its use across broader patient population
Seracal™, based on Lym-X-Sorb®, contains a proprietary lipid technology invented by David Yesair Ph.D. and exclusively licensed by Vytala